Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?

Table 1 Post liver transplantation outcomes for patients who have nonalcoholic fatty liver disease

Ref.	Study size	NASH group survival (%)	Non-NASH group survival (%)	Study period
Malik et al[62]	98 NASH	30-d - 93.9	30-d - 94.4-98.0	1997-2008
	686 Non-NASH group (PBC/PSC, ALD, HCV, CC)	1-yr - 79.6	1-yr - 81.6-87.2
		5-yr - 72.4	5-yr - 65.3-80.6
Bhagat et al[63]	71 NASH	1-yr - 82	1-yr - 92	1997-2007
	83 ALD	5-yr - 75	5-yr - 86
		9-yr - 62	9-yr - 76
Barritt et al[64]	21 NAFLD	30-d - 80.9	30-d - 97	2004-2007
	83 Non-NAFLD (ALD, HCV, HBV, PBC/PSC, AIH)	1-yr - 76.2	1-yr - 89.5
		3-yr - 76.2	3-yr - 83.5
Agopian et al[65]	144 NASH	90-d - 90	90-d - 90-96	1993-2011
	1150 Non-NASH (HBV, HCV, ALD, CC, PBC/PSC)	1-yr - 84	1-yr - 79-87
		5-yr - 75	5-yr - 54-70
Kennedy et al[66]	129 NASH	1-yr - 90	1-yr - 92	1999-2009
	775 Non-NASH - etiologies not defined	3-yr - 88	3-yr - 86
		5-yr - 85	5-yr - 80
Park et al[67]	71 NASH	1-yr - 78	1-yr - 87	1998-2008
	472 Non-NASH	2-yr - 78	2-yrs - 85
Vanwagner et al[44]	115 NASH	1-yr - 81.3	1-yr - 88.1	1993-2010
	127 ALD	3-yr - 73.3	3-yr - 85.3
		5-yr - 60.3	5-yr - 68.8
Afazali et al[68]	1810 NASH	1-yr - 87.6	Variable	1997-2010
	3843 CC	3-yr - 82.2
	48.085 Non-NASH	5-yr - 76.7
Charlton et al[14]	1959 NASH	1-yr - 84	1-yr - 87	2001-2009
	33822 Non-NASH	3-yr - 78	3-yr - 78

NAFLD: Nonalcoholic fatty liver disease; ALD: Alcoholic liver disease; HCV: Hepatitis C virus; HBV: Hepatitis B virus; CC: Cryptogenic cirrhosis; PBC: Primary biliary cirrhosis; PSC: Primary sclerosing cholangitis.